do glp 1 agonists cause muscle loss Using glp-1 receptor for weight reduction in dystrophy patients Frontiers | GLP−1 receptor agonists
Description
Available from: _Product_Information/human/001026/WC500050017.pdf
2026 Feb 23;18(4):707
Yet it is Lillys newest drug, tirzepatide, which poses a more serious threat to Novos market dominance
JAMA Netw Open 6:e237188
Patients should be advised that they may not have glycemic improvement for 24 weeks after initiating treatment with long-acting GLP-1 receptor agonists
